Investigators
- Prof. Andrew Biankin (University of Glasgow)
- Dr David Chang (University of Glasgow)
- Prof. Juan Valle (University of Manchester)
- Prof. Owen Sansom (Cancer Research UK Beatson Institute)
- Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
- Prof. Caroline Dive (Cancer Research UK Manchester Institute)
- Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
- Prof. Christopher Lord (Institute for Cancer Research)
- Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
- Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute)
Steering Committee
- Prof. Andrew Biankin (University of Glasgow) (Chair)
- Maria Cerone (CRUK)
- Dr David Chang (University of Glasgow)
- Prof. Caroline Dive (Cancer Research UK Manchester Institute)
- Ms Judith Dixon-Hughes (University of Glasgow)
- Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
- Dr Fieke Froeling (University of Glasgow)
- Dr Janet Graham (NHS Greater Glasgow and Clyde)
- Dr Derek Grose (NHS Greater Glasgow and Clyde)
- Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute)
- Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
- Mrs Caroline Kelly (University of Glasgow
- Prof. Hemant Kocher (Cancer Research UK Barts Centre)
- Prof. Christopher Lord (Institute for Cancer Research)
- Dr Lynn Matrisian (Chief Science Officer, Pancreatic Cancer Action Network)
- Prof. Colin McKay (NHS Greater Glasgow and Clyde)
- Prof. Jen Morton (University of Glasgow)
- Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
- Prof. Owen Sansom (Cancer Research UK Beatson Institute)
- Mr Jamie Stobo (University of Glasgow)
- Ms Janice Tannock (PPI Representative)
- Prof. Juan Valle (University of Manchester)
- Dr Ian Walker (CRUK)
Therapeutic Testing Board
- Prof. Owen Sansom (Cancer Research UK Beatson Institute) (Chair)
- Mr Simon Barry (AstraZeneca)
- Dr Philip Beer (University of Cambridge)
- Prof. Andrew Biankin (University of Glasgow)
- Ms Sarah Bradley (CRUK CTU Glasgow)
- Dr David Chang (University of Glasgow)
- Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
- Dr Fieke Froeling (University of Glasgow)
- Dr Janet Graham (NHS Greater Glasgow and Clyde)
- Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute)
- Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
- Mr Caroline Kelly (University of Glasgow)
- Prof. Hemant Kocher (St Bart’s)
- Prof. Christopher Lord (Institute for Cancer Research)
- Dr Mairéad McNamara (The Christie NHS Foundation Trust)
- Mr Peter Mortimer (AstraZeneca)
- Prof. Jen Morton (University of Glasgow)
- Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
- Dominic Rothwell (CRUK Institute Manchester)
- Mr Jamie Stobo (University of Glasgow)
- Prof. Juan Valle (University of Manchester)
Scientific Advisory Board
- Prof. John Primrose (Chair)
- Dr Ultan McDermott (Chief Scientist at AstraZeneca)
- Prof. Gary Middleton (Medical Oncologist, University of Birmingham)
- Dr Serena Nik-Zainal (CRUK Advanced Clinical Scientist, University of Cambridge)
- Prof. Dieter Saur (Consultant of Gastroenterology, Technical University of Munich)
- Prof. Rosie Sears (Co-director, Brenden-Colson Centre for Pancreatic Cancer, Portland, Oregon)
- Prof. Charles Swanton (Senior Group leader, Francis Crick Institute)
- Janice Tannock (Consumer Representative)
